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To the Editor––We read with interest the article by
Palumbo et al. proposing an ISPOR Code of Ethics
for Researchers. We have a number of questions
and concerns about these guidelines that we would
like to raise.
1. The article did not give information concerning
the purpose for drawing up a code of ethics.
What problems or issues have led to a code of
ethics being desirable?
2. It was unclear what central principles guide the
ISPOR Code of Ethics. Presumably the Code’s
statements are related to some broader set of
principles. It would be helpful for these to be set
out. One result of this absence of clear princi-
ples is that what is stated in the Code and what
issues are covered in the Code seem somewhat
arbitrary. What guided the task force in identi-
fying the issues and in the position taken on
those issues?
3. Most codes of practice, e.g., professional codes,
have disciplinary processes or other procedures
in place to respond to members who breach the
code. Such processes would also normally have
an appeal procedure, which could be used for
those who believed that they had been unfairly
treated by such a disciplinary process.
4. There is no review of other codes of ethics
adopted by international societies. We imagine
that the task force undertook some review of
codes of ethics. It would be helpful if such back-
ground were provided in the “background
paper” that was published. What features of
other codes were adopted, what rejected and
for what reasons?
5. There is no description of the process that led to
the ISPOR Code being drawn up. The only
information provided is that a task force was
set up and the Code has been adopted by the
ISPOR Board of Directors. It would be helpful
to know what process was adopted for conven-
ing the task force, and what principles were
used for selecting its members. There is no
description of the process that the task force, or
Directors, undertook to ensure wide and inter-
national input into the Code, or how any
responses received were dealt with in forming
the ﬁnal Code. Of particular concern is that all
the authors to the code are US based (see point
9 below), and that an Ethicist was not included
as part of the authorship team.
6. There are no clear statements about the rela-
tionship of this Code to other relevant codes of
ethics. One example is that there are many
international and national guidelines for proper
ethical conduct in the setting of medical
research and other research involving human
participants, or “human subjects” to use the
phrase in the background paper. Are the state-
ments made in this ISPOR Code supposed to
replace, supplement, or provide a commentary
on these other guidelines? Most of what is writ-
ten in the ISPOR Code deals much less thor-
oughly than these many other guidelines with
the issues covered, and also raises only a small
number of the ethical issues dealt with in the
major international and national guidelines.
Another example relates to the guidance on
listing who should be an author on a publica-
tion. The background paper correctly states
that some journals provide criteria for author-
ship. Nevertheless, many do not. It is unclear,
however, what the ISPOR Code is advising.
One way of reading the guidance is that ISPOR
members should observe the rules on author-
ship provided by JAMA regardless of which
journal is involved. It is not clear why rules set
by one journal should be followed by authors
submitting to another journal. Neither is it
clear that the principles set out for JAMA are
necessarily the correct principles.
This last point brings us to what seems to us
a major limitation of the ISPOR Code: the guid-
ance is generally rather vague. Here are a few
examples.
In the preamble, the statement is made that
“it should be generally agreed that patients are
ultimately going to experience the greatest
impact of the research conducted by ISPOR
members.” The Code goes on to give the
example that the results of research may lead
to patients being denied coverage for certain
drugs. Nevertheless, no guidance is given as to
what the responsibilities of ISPOR members
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are with regard to this issue. Is there an impli-
cation that ISPOR members should prevent, in
some way, such denial of coverage as a result
of their work?
Later on in the preamble it is stated that
research conducted by ISPOR members can
directly affect price and coverage negotiations.
What is unclear is what follows from this.
In the section on publication and dissemina-
tion, the ISPOR Code appears to say that there
is an ethical requirement for members to pub-
licly disseminate all their work. The guidance
states: “It has been suggested that withholding
publication is unethical.” It is unclear whether
this Code endorses the view that it is unethical
or takes the contrary view and is mentioning
this suggestion because this Code takes a differ-
ent view. If this is to be a code of ethics then it
must state clearly what the code is, not simply
draw attention to the suggestions of others.
Assuming the ISPOR Code endorses the view
that it is unethical to withhold publication, we
were then surprised to read that contractual
rights restricting publication must be respected.
This raises the question of whether a contract
should ever be entered into by ISPOR members
that limits the publication of data. The Society’s
journal 
 
Value in Health
 
 requires authors to sign
a statement that publication rights were not
restricted for any article submitted to the jour-
nal, but this is not mentioned in the Code. The
Code does state that some universities refuse to
sign a contract where publication rights are
restricted,  but  again,  the  Code  fails  to
take  a view. So what is the guidance to ISPOR
members?
7. There are a number of statements that seem to
us out of place in a code of ethics. One example
is the ﬁrst sentence of the preamble which states
that “As an overriding precept, it would be pru-
dent to say that an ISPOR researcher’s ﬁrst rela-
tionship is. . . .” The word “prudent” here
seems strange. It suggests that these guidelines
may not be based on ethical principles at all but
are simply advice as to what is in the best inter-
ests of ISPOR researchers.
8. The article as a whole seems to us to be written
entirely from a US perspective, reﬂecting per-
haps the wholly US authorship. Our own per-
spective—that of the UK—must be closer to the
US perspective than that of many of the coun-
tries that an international society must include.
And yet, even from a UK perspective the whole
Code appears highly parochial. This is evident
in the vocabulary, e.g., referring to what in the
UK are called research ethics committees by
using only the US phrase (institutional research
review boards); the reference list is (almost)
entirely US papers; the only reference to any rel-
evant report of a set of principles guiding med-
ical researchers is to the Belmont Report; and in
talking about employment law, or in the pre-
sumptions of the organization of medical serv-
ices, it is exclusively a US perspective that is
provided.
9. Finally, the Code itself is somewhat contradic-
tory in calling for ISPOR to assure that its jour-
nal, Value in Health, only publishes papers that
have gone through a rigorous peer-review proc-
ess. As an ISPOR-sponsored Task Force report,
the article was not subjected to the usual rigor-
ous peer-review process that the Editorial
Board of Value in Health demands. Although
the (unreported) process of producing these
Task Force reports includes inviting comment
on the draft report from a large proportion of
the ISPOR membership, it would appear to be
all too easy to be seduced into thinking that this
is an appropriate substitute for anonymous
peer review.
We are concerned that if the Code of Ethics for
ISPOR is adopted as currently written, and with-
out a more thorough account being given of the
process by which it has been developed, it will
damage the reputation of the Society and will
alienate many of its members, particularly those
who are not from the United States.—Tony Hope,
Professor of Medical Ethics, University of Oxford,
Andrew Briggs, BA, MSc, DPhil, Public Health
Career Scientist, University of Oxford and Coedi-
tor, Value in Health.
